US Stock MarketDetailed Quotes

PBAXW PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM)

Watchlist
  • 0.0501
  • 0.00000.00%
Close Feb 14 16:00 ET
0Market Cap0.00P/E (TTM)

About PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) Company

Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team’s background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe.

Company Profile

SymbolPBAXW
Company NamePHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM)
CEOMr. Chris Ehrlich
MarketNASDAQ
Employees3
Securities TypeOrdinary Shares
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Chris Ehrlich
  • Chief Executive Officer and Director
  • --
  • Daniel Corey
  • Director and Chief Technical Officer
  • --
  • Daniel E. Geffken, M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Brian G. Atwood
  • Chairman of the Board
  • --
  • Dr. Douglas Fisher, M.D.
  • President
  • --
  • Kathleen D. Laporte
  • Independent Director
  • --
  • Caroline M. Loewy
  • Independent Director
  • --
  • Michael Byrnes
  • Independent Director
  • --
  • Barbara Kosacz, J.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg